• $367,920.00
    Market Cap
  • -17.78%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 65
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.37
$0.38
$0.37
1-Year Range
$0.0002
$0.40
$0.37
Latest Close$0.37
Change
+$0.02 (+5.41%)
Volume909
Market Cap$367,920.00
Shares Outstanding994,379
P/E (TTM)3,700.00
Diluted EPS (TTM)$0.0001
Enterprise Value$390,309.00

Information as of 09/09/2026

Company Profile

TRAFALGAR INTERNATIONAL, INC.
https://www.gcanrx.com
$367,920.00
Market Cap
-$36,099.00
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
200 South Biscayne Blvd, Miami, FL, United States, 33131
443 738 4051

Trafalgar International, Inc. focuses on acquiring, developing and growing businesses in the financial services, technology and intellectual property sectors. The company was formerly known as The Greater Cannabis Company, Inc. and changed its name to Trafalgar International, Inc. in July 2026. The company was founded in 2014 and is based in Miami, Florida.

Key Executives

  • Motti Stenge
  • Adi Aran
  • Porfirio Sanchez-Talavera
  • Michelle Cervantes Vivanco
  • Carlos Septien Michel

Current Ownership Distribution

  • Insiders23.1M (100.00%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)
  • Other0 (0.00%)